Evidence map›Paper›PMID 28216317›Full record

ArticleCurrent biology : CB2017

Tropomyosin Isoforms Specify Functionally Distinct Actin Filament Populations In Vitro.

Gergana Gateva, Elena Kremneva, Theresia Reindl, Tommi Kotila, Konstantin Kogan, Laurène Gressin, Peter W Gunning, Dietmar J Manstein, Alphée Michelot, Pekka Lappalainen

Open access · bronzeAbstract read
In one paragraph

Article in Current biology : CB, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 174 citations in OpenAlex.

  1. Article
  2. Alterations of actin in aging.Journal of cell science · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Gergana GatevaInstitute of Biotechnology, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland.
Elena KremnevaInstitute of Biotechnology, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland.
Theresia ReindlInstitute for Biophysical Chemistry, Hannover Medical School, 30625 Hannover, Germany.
Tommi KotilaInstitute of Biotechnology, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland.
Konstantin KoganInstitute of Biotechnology, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland.
Laurène GressinBiosciences and Biotechnology Institute of Grenoble, LPCV/CNRS/CEA/UGA/INRA, 38054 Grenoble, France.
Peter W GunningOncology Research Unit, School of Medical Sciences, UNSW Australia, Sydney, NSW 2052, Australia.
Dietmar J MansteinInstitute for Biophysical Chemistry, Hannover Medical School, 30625 Hannover, Germany.
Alphée MichelotAix-Marseille University, CNRS, IBDM, 13284 Marseille, France.
Pekka LappalainenInstitute of Biotechnology, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland. Electronic address: pekka.lappalainen@helsinki.fi.
University of Helsinki · FIBiocenter Finland · FIMax Planck Institute for Biophysical Chemistry · DEAix-Marseille Université · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actin filaments assemble into a variety of networks to provide force for diverse cellular processes [1]. Tropomyosins are coiled-coil dimers that form head-to-tail polymers along actin filaments and regulate interactions of other proteins, including actin-depolymerizing factor (ADF)/cofilins and myosins, with actin [2-5]. In mammals, >40 tropomyosin isoforms can be generated through alternative splicing from four tropomyosin genes. Different isoforms display non-redundant functions and partially non-overlapping localization patterns, for example within the stress fiber network [6, 7]. Based on cell biological studies, it was thus proposed that tropomyosin isoforms may specify the functional properties of different actin filament populations [2]. To test this hypothesis, we analyzed the properties of actin filaments decorated by stress-fiber-associated tropomyosins (Tpm1.6, Tpm1.7, Tpm2.1, Tpm3.1, Tpm3.2, and Tpm4.2). These proteins bound F-actin with high affinity and competed with α-actinin for actin filament binding. Importantly, total internal reflection fluorescence (TIRF) microscopy of fluorescently tagged proteins revealed that most tropomyosin isoforms cannot co-polymerize with each other on actin filaments. These isoforms also bind actin with different dynamics, which correlate with their effects on actin-binding proteins. The long isoforms Tpm1.6 and Tpm1.7 displayed stable interactions with actin filaments and protected filaments from ADF/cofilin-mediated disassembly, but did not activate non-muscle myosin IIa (NMIIa). In contrast, the short isoforms Tpm3.1, Tpm3.2, and Tpm4.2 displayed rapid dynamics on actin filaments and stimulated the ATPase activity of NMIIa, but did not efficiently protect filaments from ADF/cofilin. Together, these data provide experimental evidence that tropomyosin isoforms segregate to different actin filaments and specify functional properties of distinct actin filament populations.

Indexed as

Actin CytoskeletonAmino Acid SequenceHumansProtein BindingProtein IsoformsStress FibersTropomyosinProtein IsoformsTropomyosinactinadhesioncell migrationcofilincytoskeletonmyosinstress fiberTIRF microscopytropomyosinα-actinin

Identifiers

PMID28216317
PMCPMC5344678
OpenAlexW2588726331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.